Axsome Therapeutics Inc (STU:19X) Stock News, Headlines & Updates
Axsome Therapeutics Inc Stock News from GuruFocus
- 1
- 2
Jul 09, 2025
Axsome Therapeutics to Report Second Quarter 2025 Financial Results on August 4 | AXSM Stock News
GuruFocus News • 6:20am
Axsome Therapeutics Inc (AXSM) Announces Upcoming Q2 2025 Financial Results Release | AXSM stock news
GuruFocus News • 6:03am
Axsome Therapeutics to Report Second Quarter 2025 Financial Results on August 4
Marketwired • 6:00am
Jul 07, 2025
Axsome Therapeutics to Showcase Its Innovative CNS Pipeline at Upcoming Frontiers in Brain Health R&D Day in New York City on July 21 | AXSM Stock News
GuruFocus News • 6:20am
Axsome Therapeutics Inc (AXSM) Announces Frontiers in Brain Health R&D Day | AXSM stock news
GuruFocus News • 6:01am
Axsome Therapeutics to Showcase Its Innovative CNS Pipeline at Upcoming Frontiers in Brain Health R&D Day in New York City on July 21
Marketwired • 6:00am
Jul 03, 2025
Axsome Therapeutics (AXSM) Target Price Announced by Morgan Stanley | AXSM Stock News
GuruFocus News • 1:30pm
Jun 20, 2025
Axsome Therapeutics (AXSM) Supports Alzheimer's Awareness Initiatives | AXSM Stock News
GuruFocus News • 6:48am
Axsome Therapeutics Champions Brain Health During Alzheimer's & Brain Awareness Month | AXSM Stock News
GuruFocus News • 6:17am
Axsome Therapeutics Inc (AXSM) Joins Alzheimer's Awareness Efforts | AXSM stock news
GuruFocus News • 6:02am
Axsome Therapeutics Champions Brain Health During Alzheimer's & Brain Awareness Month
Marketwired • 6:00am
Jun 18, 2025
Axsome Therapeutics to Present Data Spanning the SYMBRAVO® (meloxicam and rizatriptan) Clinical Program at the 67th Annual Scientific Meeting of the American Headache Society (AHS) | AXSM Stock News
GuruFocus News • 6:19am
Axsome Therapeutics Inc (AXSM) to Present SYMBRAVO® Data at American Headache Society Meeting | AXSM stock news
GuruFocus News • 6:01am
Axsome Therapeutics to Present Data Spanning the SYMBRAVO® (meloxicam and rizatriptan) Clinical Program at the 67th Annual Scientific Meeting of the American Headache Society (AHS)
Marketwired • 6:00am
Jun 16, 2025
Axsome Therapeutics (AXSM) Supports Migraine Awareness and Community Events | AXSM Stock News
GuruFocus News • 6:48am
Axsome Therapeutics Proudly Supports Migraine and Headache Awareness Month Alongside the Association of Migraine Disorders | AXSM Stock News
GuruFocus News • 6:19am
Axsome Therapeutics Inc (AXSM) Supports Migraine Awareness with Nationwide Initiatives | AXSM stock news
GuruFocus News • 6:04am
Axsome Therapeutics Proudly Supports Migraine and Headache Awareness Month Alongside the Association of Migraine Disorders
Marketwired • 6:00am
Jun 12, 2025
RBC Capital Adjusts Price Target for AXSM, Maintains Outperform Rating | AXSM Stock News
GuruFocus News • 11:00am
Axsome Therapeutics (AXSM) Target Price Adjusted by RBC Capital | AXSM Stock News
GuruFocus News • 8:46am
Jun 11, 2025
Axsome Therapeutics Showcases Innovation in Sleep Medicine with Multiple Presentations for AXS-12 and Solriamfetol at SLEEP 2025 | AXSM Stock News
GuruFocus News • 6:21am
Axsome Therapeutics Inc (AXSM) Showcases Promising CNS Treatments at SLEEP 2025 Conference | AXSM stock news
GuruFocus News • 6:06am
Axsome Therapeutics Showcases Innovation in Sleep Medicine with Multiple Presentations for AXS-12 and Solriamfetol at SLEEP 2025
Marketwired • 6:00am
Jun 10, 2025
Axsome Therapeutics (AXSM) Launches SYMBRAVO for Migraine Relief in the U.S. | AXSM Stock News
GuruFocus News • 6:32am
Axsome Therapeutics (AXSM) Stock Rating Reiterated with Buy Recommendation | AXSM Stock News
GuruFocus News • 6:30am
Axsome Therapeutics Announces Availability of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults | AXSM Stock News
GuruFocus News • 6:29am
Axsome Therapeutics Announces Availability of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults
Marketwired • 6:00am
Jun 09, 2025
Axsome Therapeutics (AXSM) Faces FDA Setback for AXS-14 Application | AXSM Stock News
GuruFocus News • 12:15pm
Axsome Therapeutics (AXSM) Faces Setback After FDA Declines AXS-14 Review
GuruFocus News • 8:58am
Axsome Therapeutics (AXSM) Price Target Adjusted by Needham Analyst | AXSM Stock News
GuruFocus News • 7:31am
Axsome Therapeutics (AXSM) Faces FDA Setback for Fibromyalgia Drug | AXSM Stock News
GuruFocus News • 7:03am
Axsome Therapeutics Provides Update on the New Drug Application (NDA) for AXS-14 for the Management of Fibromyalgia | AXSM Stock News
GuruFocus News • 6:21am
Axsome Therapeutics Inc (AXSM) Receives FDA Refusal to File Letter for AXS-14 NDA | AXSM stock news
GuruFocus News • 6:02am
Axsome Therapeutics Provides Update on the New Drug Application (NDA) for AXS-14 for the Management of Fibromyalgia
Marketwired • 6:00am
Jun 03, 2025
Oppenheimer Initiates Axsome Therapeutics (AXSM) with Outperform Rating
GuruFocus News • 11:55am
Oppenheimer Initiates Coverage on Axsome Therapeutics (AXSM) with Outperform Rating | AXSM Stock News
GuruFocus News • 10:31am
Axsome Therapeutics (AXSM) Gains Positive Outlook with Analyst Coverage | AXSM Stock News
GuruFocus News • 7:02am
May 29, 2025
Axsome Therapeutics Inc (AXSM) Announces Participation in Upcoming Investor Conferences | AXSM stock news
GuruFocus News • 6:06am
Axsome Therapeutics to Participate in Upcoming Investor Conferences
Marketwired • 6:00am
May 28, 2025
- 1
- 2
Show
Entries
Headlines
Total 0- 1
No recent news